Related Experiment Video
Updated: May 14, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Hypertension, its treatment, hyperuricaemia and gout
1Department of Rheumatology, Guys and St Thomas Hospitals, London, UK. Terence.Gibson@kcl.ac.uk
Insights
Hyperuricemia, a condition of high uric acid, is increasingly linked to hypertension. Emerging evidence suggests hyperuricemia may cause hypertension, challenging traditional views and highlighting the need for new treatments.
Area of Science:
- Nephrology
- Rheumatology
- Cardiology
Background:
- Gout and hyperuricemia are increasingly prevalent globally.
- Established association between hyperuricemia, gout, hypertension, and chronic kidney disease.
- Causal relationship between these conditions remains controversial.
Purpose of the Study:
- To review studies addressing the complex relationship between hyperuricemia and hypertension.
- To evaluate evidence for hyperuricemia as a cause of hypertension.
- To explore the impact of diuretics on hyperuricemia and hypertension.
Main Methods:
- Systematic review of epidemiological surveys and relevant studies.
- Analysis of data on hyperuricemia, hypertension, and associated confounders.
- Examination of proposed mechanisms for diuretic-induced hyperuricemia.
Main Results:
- Strong epidemiological evidence links gout and hyperuricemia with hypertension and diuretic use.
- Hyperuricemia is suggested to directly cause hypertension and renovascular disease.
- Diuretic-induced hyperuricemia may result from volume depletion and reduced uric acid secretion, potentially influenced by genetics.
Conclusions:
- Recent data challenge the notion that renal dysfunction or shared factors solely explain the hyperuricemia-hypertension link.
- Evidence suggests hyperuricemia actively contributes to hypertension development.
- Development of uricosuric diuretics is needed, and losartan shows promise for hypertensive patients with gout.
Purpose Of Review:
Gout is increasing worldwide. An appreciation that hyperuricaemia and gout are associated with hypertension and chronic kidney disease is well established, but the cause and effect relationships are controversial. Studies which address this conundrum have been reviewed.
Recent Findings:
Epidemiological surveys have confirmed the strong relationship of gout and hyperuricaemia with hypertension and diuretic treatment. There are multiple confounders such as obesity and alcohol consumption which despite adjustments make interpretation of the epidemiology difficult. There are data to suggest that hyperuricaemia itself causes hypertension and renovascular disease, and that lowering of serum urate may assist in control of hypertension. The mechanism for diuretic-induced hyperuricaemia may operate through volume depletion and reduced secretion of uric acid. The latter effect may be genetically influenced.
Summary:
Recent population surveys have strongly supported the association of gout and hyperuricaemia with hypertension. The prevailing explanation that renal dysfunction causes both phenomena or that they are caused by shared factors is challenged by the evidence that hyperuricaemia drives hypertension. A confounder of epidemiology studies is the use of diuretics for treating hypertension. A closer understanding of the mechanisms of diuretic-induced hyperuricaemia may lead to the creation of uricosuric diuretics. Losartan is exceptional amongst antihypertensive drugs in possessing mild uricosuric properties and therefore has a role in treating hypertensive patients with gout. Overcoming diuretic-induced hyperuricaemia is difficult and there is need for a uricosuric diuretic.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Antihypertensive Drugs: Action of Diuretics
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Urinary Tract Calculi V: Nursing Management